Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

In modern information technology, the efficient and dynamic manipulation of these light "codes" is key to achieving ...

Many cutting-edge technologies, ranging from augmented reality (AR) and virtual reality (VR) to LiDAR (light detection and ranging) systems, rely on components that enable the precise control of light ...

Polyphenol-rich berries may improve insulin sensitivity, regulate leptin, and modestly boost memory while influencing amyloid and tau pathways in obesity-related decline.

Equity-Insider.com News Commentary — Psychedelic compounds are edging closer to regulatory approval as pivotal trials in ...

Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to geophysical exploration and biomedical sensing. Their performance critically ...

EET Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Funding to support ...

Executives from Equillium (NASDAQ:EQ) outlined the scientific rationale and near-term development plans for its lead program, EQ504, during a recent fireside chat focused on immunology and ...

Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. Click ...